Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhenwu Li
Institution:
Incyte (United States)
Observed institutions:
SK Life Science (United States),
Incyte (United States)
ORCID:
0000-0003-0962-5931
Observed ORCID:
0000-0003-0962-5931
OpenAlex ID:
A5068148700
Discovery of INCB159020, an Orally Bioavailable KRAS G12D Inhibitor
2025
·
Qinda Ye
, Artem Shvartsbart
, et al.
·
Journal of Medicinal Chemistry
·
18
Discovery of High-Affinity SMARCA2/4 Bromodomain Ligands and Development of Potent and Exceptionally Selective SMARCA2 PROTAC Degraders
2025
·
Lingying Leng
, Wenbin Tu
, et al.
·
Journal of Medicinal Chemistry
·
17
Discovery of Potent, Highly Selective, and Efficacious SMARCA2 Degraders
2024
·
Zhenwu Li
, Lalgudi S. Harikrishnan
, et al.
·
Journal of Medicinal Chemistry
·
6
Discovery of INCB161734: A Selective Inhibitor of the KRAS G12D Mutant
2026
·
Alexander Sokolsky
, Haolin Yin
, et al.
·
Journal of Medicinal Chemistry
Show more works
View as search
Works count:
4
Citation count:
41
H-index:
3
I10-index:
2
Year
Topic
Type
